Gender & Health

Published by
New York Times
|
By |
When a Congressional investigation revealed in June that Dr. Joseph Biederman, a world-renowned child psychiatrist, had earned far more money from drug makers than he had reported to his university, he said that his interests were "solely in the advancement of medical treatment through rigorous and objective study." Read More
Published by
The New York Times
|
By |
An influential psychiatrist who was the host of the popular NPR program "The Infinite Mind" earned at least $1.3 million from 2000 to 2007 giving marketing lectures for drugmakers, income not mentioned on the program. Read More
Published by
San Francisco Chronicle
|
By |
Ivory Coast plantation workers who claim they were sterilized by a U.S.-made pesticide can't sue the manufacturers and distributors of the chemical in the United States because they can't show the companies intended to harm them, a federal appeals court ruled Wednesday. Read More
Published by
ABC News
|
By |
Michaela, a deceased 5 month old, is one of more than 13,000 Argentine children to participate in a clinical study implemented a little more than a year ago by the London-based GlaxoSmithKline, the world's second-largest drug manufacturer. Read More
Published by
Special to CorpWatch
|
By |
Globally, Toyota is known for its innovation and quality of products like the Prius hybrid. A closer look at operations in Japan, the Philippines, Myanmar and the U.S. reveals a story of extreme working conditions, union-busting and other corporate abuses. In Japan and elsewhere, workers are speaking out. Read More
Published by
The New York Times
|
By |
A federal judge in Brooklyn decided on Friday to unseal confidential materials about Eli Lilly's top-selling antipsychotic drug Zyprexa, citing "the health of hundreds of thousands of people" and "fundamental questions" about the way drugs are approved for new uses. Read More
Published by
The New York Times
|
By |
About the only point on which both sides agree is that no one can judge ezetimibe's safety and benefits for certain without more data, ideally from a clinical trial covering more than 10,000 patients and lasting several years, long enough to show that the drug actually helps patients live longer or avoid heart attacks. Read More
Published by
Special to CorpWatch
|
By |
Multinational industries like tobacco and alcohol have responded to increased global public pressure for accountability around corporate operations by creating Voluntary Codes of Conduct to self-regulate their behavior. But how are the results measuring up? Read More
Published by
New York Times
|
By |
West Virginia Governor Joe Manchin III filed a friend-of-the-court brief in June, arguing the State Supreme Court should review a $382 million judgment against DuPont. The case involves thousands of residents in the area of a DuPont-operated zinc-smelting plant, and the largest civil penalty ever levied against the company, for the dumping of toxic arsenic, cadmium and lead at the plant. Read More
Published by
Special to CorpWatch
|
By |
Entergy Nuclear (part of the broader Entergy energy family) is spinning off its northeastern U.S.-based nuclear power plants into a related limited liability corporation, Enexus. Stakeholders in Vermont, home of the Yankee Nuclear power plant, are less than happy, with Entergy also reneging on prior commitments to cover eventual plant decommissioning costs, potentially stranding taxpayers with much of the bill. Read More
* indicates required